Tuesday, November 2, 2021

£12.2m boost for coronavirus genomic surveillance




The COVID-19 Genomics UK (COG-UK) Consortium is being given £12.2 million from the Department for Health and Social Care Testing Innovation Fund to expand whole genome sequencing of positive SARS-CoV-2 virus samples.

The funding will facilitate the genome sequencing capacity needed to meet the expected rise in COVID-19 cases in the UK this winter, which will help to map how the virus spreads and evolves.

The investment enables COG-UK to grow and strengthen current genomic surveillance efforts spearheaded by the Wellcome Sanger Institute and the University of Cambridge, together with the four UK Public Health Agencies and other COG-UK partners, to boost sequencing capacity and cut  turnaround time from sample to genome sequence.

It is hoped that integrating real-time sequencing data within the four UK Public Health Agencies and NHS Test and Trace will not only help strengthen infection control measures but also the identification of patterns that might reveal otherwise unidentifiable opportunities for intervention.

Led by Professor Sharon Peacock of the University of Cambridge & Director Of Science at Public Health England, COG-UK is an innovative partnership of NHS organisations, the four Public Health Agencies of the UK, the Wellcome Sanger Institute and 12 academic institutions from across the UK providing world leading expertise in SARS-CoV-2 genomics and supporting sequencing and analysis capacity nationwide.

“To fully understand the spread and evolution of the SARS-CoV-2 virus, we must sequence and analyse the viral genomes,” said Professor Sharon Peacock, director of the COG-UK Consortium, Professor of Public Health and Microbiology at the University of Cambridge and a director Of Science (Pathogen Genomics) at Public Health England.

“The pattern of accumulation of mutations in the genomes enables us to determine the relatedness of virus samples and define viral lineages in order to understand whether local outbreaks are caused by transmission of single or multiple viral lineages. Analysis of viral genome sequences also allow us to monitor the evolution of SARS-CoV-2 and assess whether specific mutations influence transmission, disease severity, or the impact of interventions such as vaccines.”



Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...